InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer [Yahoo! Finance]
InMed Pharmaceuticals Inc. - Common Shares (INM)
Company Research
Source: Yahoo! Finance
the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today announced the appointment of Ms. Netta Jagpal, CPA, CA as Chief Financial Officer and Corporate Secretary, effective February 20, 2024. "We are excited to welcome Ms. Jagpal to InMed and are fortunate to have someone of her caliber and experience join our executive leadership team," commented Eric A. Adams, President and Chief Executive Officer. "Netta has served in leadership positions with multiple public and private companies and brings a wealth of experience in the biotech industry. Netta's experience in leading all aspects of the finance and accounting functions makes her an ideal candidate to support both InMed's core pharmaceutical drug development business and BayMedica's commercial enterprise." Ms. Jagpal joins InMed with over 20 years of experience in financial leadership roles, primarily in the biotech industry. Prior to InMed, Ms. Jagpal served as Vice P
Show less
Read more
Impact Snapshot
Event Time:
INM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INM alerts
High impacting InMed Pharmaceuticals Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
INM
News
- InMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer's Expert, to the Company's Scientific Advisory Board [Yahoo! Finance]Yahoo! Finance
- InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration [Yahoo! Finance]Yahoo! Finance
- InMed's INM-901 Demonstrates Favorable Pharmacological and Behavioral Effects in In Vivo Preclinical Alzheimer's Disease Studies [Yahoo! Finance]Yahoo! Finance
- InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance [Yahoo! Finance]Yahoo! Finance
- InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
INM
Sec Filings
- 4/18/24 - Form 8-K
- 4/16/24 - Form 8-K
- 4/5/24 - Form 8-K
- INM's page on the SEC website